Skip to content

Drug interactions

Cannabidiol + Tranylcypromine

Severity: Moderate

Cannabidiol and Tranylcypromine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tranylcypromine inhibits CYP2C19 to a modest degree and may raise cannabidiol levels, increasing sedation, somnolence and possibly liver enzyme elevations. The effect is generally manageable.

What this interaction means in plain words

Cannabidiol and Tranylcypromine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cannabidiol belongs to Central Nervous System; Tranylcypromine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Inhibition of CYP2C19-mediated cannabidiol metabolism by tranylcypromine.

What to do

Monitor for sedation and adverse effects, and consider lowering the cannabidiol dose. Check liver enzymes if clinically indicated.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cannabidiol and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cannabidiol with Tranylcypromine?

MediHelp rates the interaction as moderate. Cannabidiol and Tranylcypromine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tranylcypromine inhibits CYP2C19 to a modest degree and may raise cannabidiol levels, increasing sedation, somnolence and possibly liver enzyme elevations. The effect is generally manageable.

How serious is the interaction between Cannabidiol and Tranylcypromine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for sedation and adverse effects, and consider lowering the cannabidiol dose. Check liver enzymes if clinically indicated.

What other medicines interact with Tranylcypromine?

MediHelp also lists interactions of Tranylcypromine with, for example, 5-HTP, Amitriptyline, Amoxapine. The full list is on the Tranylcypromine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in